Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 27, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020675

« Back to Dashboard
NDA 020675 describes URSO FORTE, which is a drug marketed by Forest Labs Inc and is included in one NDA. It is available from four suppliers. Additional details are available on the URSO FORTE profile page.

The generic ingredient in URSO FORTE is ursodiol. There are five drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the ursodiol profile page.

Summary for NDA: 020675

Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 020675

Ingredient-typeBile Acids and Salts

Suppliers and Packaging for NDA: 020675

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
URSO 250
TABLET;ORAL 020675 NDA AUTHORIZED GENERIC Actavis Pharma, Inc. 0591-2998 0591-2998-01 100 TABLET in 1 BOTTLE (0591-2998-01)
URSO 250
TABLET;ORAL 020675 NDA AUTHORIZED GENERIC Actavis Pharma, Inc. 0591-3005 0591-3005-01 100 TABLET in 1 BOTTLE (0591-3005-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength250MG
Approval Date:Dec 10, 1997TE:ABRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength500MG
Approval Date:Jul 21, 2004TE:ABRLD:Yes

Expired Orange Book Patents for NDA: 020675

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Forest Labs Inc
URSO 250
TABLET;ORAL020675-001Dec 10, 19974,859,660► Subscribe
Forest Labs Inc
TABLET;ORAL020675-002Jul 21, 20044,859,660► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus